ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1063

Use of Telemedicine for Rheumatology Practice in Queensland, Australia: Experiences Before and During the COVID-19 Pandemic

Divita Jhaveri1, Faith Alele2, Aleisha Strom3, Theophilus Emeto2 and Helen Benham4, 1Rheumatology Department, Princess Alexandra Hospital, Woolloongabba, Australia, 2Public Health & Tropical Medical, College of Public Health, Medical & Veterinary Sciences. James Cook University, Townsville, QLD, Australia, 3Internal Medicine Department, Townsville University Hospital, Angus Smith Dr, Douglas, QLD 4811, Townsville, Australia, 4Faculty of Medicine, The University of Queensland, Herston, Australia

Meeting: ACR Convergence 2021

Keywords: telemedicine, Telerheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Health Services Research Poster II: Care Models and Innovation (1061–1082)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: In Australia there is a nationwide rheumatologist shortage potentially translating to poorer clinical outcomes for those living with rheumatic diseases. 1 A possible solution to improve patient care in this setting is telemedicine (TM). During the COVID-19 pandemic TM consultations increased significantly resulting in an opportunity to review rheumatologists’ use of TM. The aim of this study was to examine the utilisation and provider perceptions of TM in rheumatology. This study investigated the usage of TM by rheumatologists before and during the COVID-19 pandemic and explored the models of care utilised and the challenges experienced.

Methods: A sequential mixed-methods study design was adopted and rheumatologists completed a questionnaire including demographics, clinical practice, TM uptake, models of care applied and clinician perceptions of TM. The qualitative phase utilised purposeful sampling of active users of TM through in-depth semi-structured interviews. The impact of COVID 19 pandemic on TM use for rheumatology practise was explored.

Results: Thirty Queensland rheumatologists participated in surveys with 76.7% actively utilising TM. Usage of TM was limited prior to the COVID-19 with 9.5% seeing more than 5 patients per week. Patient populations served by TM included capital city (n=16, 53.3%), regional (n=19, 63.3%) and rural/remote (n=7, 23.3 %). A significant association between rheumatologists (n=29) having ever practised in a rural/remote setting (n=19, 65.5%) and use of TM within the last 24 months (n=17, 58.62%), p=0.030 was seen with no association found for formal training in TM or years of experience as a rheumatologist and TM usage. Of the active TM users prior to the COVID-19 pandemic 90% commenced conventional DMARDs and 55% biological DMARDS through TM. One of the major barriers to wider usage included low to medium confidence with joints assessments through TM (n= 15/19). Qualitative analysis further identified barriers to TM uptake including limited distribution of technology, administrative and peripheral clinical staff involvement and lack of financial incentives particularly in the private sector. During the COVID-19 pandemic, a significant expansion of TM as telephone calls occurred with rheumatologists reporting low confidence and satisfaction with this, whilst identifying that telephone calls and TM may be an acceptable model for monitoring stable patients with low disease activity.

Conclusion: Familiarity with TM exists in this rheumatology cohort, however its usage in routine practise is limited due to multiple barriers. The COVID 19 pandemic highlighted lower confidence in telephone calls as a form of TM and concerns regarding new or unstable patients.


Disclosures: D. Jhaveri, None; F. Alele, None; A. Strom, None; T. Emeto, None; H. Benham, None.

To cite this abstract in AMA style:

Jhaveri D, Alele F, Strom A, Emeto T, Benham H. Use of Telemedicine for Rheumatology Practice in Queensland, Australia: Experiences Before and During the COVID-19 Pandemic [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/use-of-telemedicine-for-rheumatology-practice-in-queensland-australia-experiences-before-and-during-the-covid-19-pandemic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-telemedicine-for-rheumatology-practice-in-queensland-australia-experiences-before-and-during-the-covid-19-pandemic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology